Kathleen Glaub

Ms. Kathleen S.
Glaub is a Chief Executive Officer at CuraSen Therapeutics, Inc. She is on the Board of Directors at IO Biotech ApS.
Ms. Glaub was previously employed as an Independent Director by Aligos Therapeutics, Inc., a Chairman by Escient Pharmaceuticals, Inc., an Independent Director by IO Biotech, Inc., an Independent Director by Codexis, Inc., a Chief Executive Officer & Director by Afferent Pharmaceuticals, Inc., a President by Plexxikon, Inc., a Chief Financial Officer & Senior Vice President by Cell Genesys, Inc., a Treasurer by Genentech, Inc., and a Principal by Intel Corp.
She received her undergraduate degree from the University of California, Berkeley and an MBA from Kellogg School of Management.